Mega Lifesciences Public Company Limited (MEGA.BK)
THB 32.75
(0.0%)
THB 32.75
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 15.68 Billion | 15.68 Billion | 14.13 Billion | 12.58 Billion | 11.12 Billion | 10.34 Billion |
| Cost of Revenue | 8.7 Billion | 8.64 Billion | 8.22 Billion | 7.6 Billion | 6.55 Billion | 5.75 Billion |
| Gross Profit | 6.97 Billion | 7.03 Billion | 5.91 Billion | 4.98 Billion | 4.57 Billion | 4.59 Billion |
| Operating Expenses | 4.07 Billion | 4.35 Billion | 3.76 Billion | 3.29 Billion | 3.17 Billion | 3.24 Billion |
| Selling, General and Administrative Expenses | 4.03 Billion | 4.19 Billion | 3.61 Billion | 3.16 Billion | 3.09 Billion | 3.15 Billion |
| Research and Development Expenses | 41.31 Million | 44.39 Million | 40.52 Million | 27.37 Million | 27.15 Million | 29.21 Million |
| Other Expenses | - | 120.71 Million | 117.22 Million | 107.74 Million | 51.34 Million | 101.88 Million |
| Cost and Expenses | 12.77 Billion | 13 Billion | 11.99 Billion | 10.9 Billion | 9.72 Billion | 8.99 Billion |
| Operating Income | 2.9 Billion | 2.72 Billion | 2.17 Billion | 1.66 Billion | 1.42 Billion | 1.44 Billion |
| Interest Expense | 31.25 Million | 28.73 Million | 28.27 Million | 72.27 Million | 65.15 Million | 33.97 Million |
| Income Tax Expense | 269.05 Million | 354.63 Million | 336.02 Million | 234.32 Million | 160.02 Million | 202.75 Million |
| Earnings before Tax | 2.26 Billion | 2.59 Billion | 2.27 Billion | 1.62 Billion | 1.29 Billion | 1.4 Billion |
| Net Income | 1.99 Billion | 2.24 Billion | 1.94 Billion | 1.39 Billion | 1.13 Billion | 1.2 Billion |
| Earnings Per Share Basic | 2.29 | 2.57 | 2.23 | 1.60 | 1.31 | 1.39 |
| Earnings Per Share Diluted | 2.29 | 2.57 | 2.23 | 1.60 | 1.31 | 1.39 |
| Weighted Average Shares Outstanding | 871.87 Million | 871.87 Million | 871.87 Million | 871.87 Million | 870.84 Million | 865.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 871.87 Million | 871.87 Million | 871.87 Million | 871.87 Million | 870.84 Million | 869.04 Million |
| Gross Margin | 0.45 | 0.45 | 0.42 | 0.40 | 0.41 | 0.44 |
| EBIT Margin | 0.16 | 0.19 | 0.17 | 0.15 | 0.14 | 0.15 |
| Profit Margin | 0.13 | 0.14 | 0.14 | 0.11 | 0.10 | 0.12 |
| EBITDA | 2.57 Billion | 2.89 Billion | 2.58 Billion | 1.99 Billion | 1.53 Billion | 1.59 Billion |
| Earnings Before Tax Margin | 0.19 | 0.17 | 0.15 | 0.13 | 0.13 | 0.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 3.95 Billion | 3.73 Billion | 4.15 Billion | 15.68 Billion | 3.8 Billion | 3.99 Billion |
| Cost of Revenue | 2.03 Billion | 1.98 Billion | 2.25 Billion | 8.7 Billion | 2.06 Billion | 2.16 Billion |
| Gross Profit | 1.91 Billion | 1.74 Billion | 1.9 Billion | 6.97 Billion | 1.73 Billion | 1.82 Billion |
| Operating Expenses | 1.13 Billion | 1.06 Billion | 1.1 Billion | 4.07 Billion | 1.02 Billion | 1.03 Billion |
| Selling, General and Administrative Expenses | 1.13 Billion | 1.06 Billion | 1.1 Billion | - | 1.02 Billion | 1.03 Billion |
| Research and Development Expenses | - | - | 41.31 Million | - | - | - |
| Other Expenses | 13.16 Million | 6.99 Million | 8.78 Million | 34.41 Million | 8.5 Million | 8.61 Million |
| Cost and Expenses | 3.17 Billion | 3.05 Billion | 3.35 Billion | 12.77 Billion | 3.08 Billion | 3.2 Billion |
| Operating Income | 776.15 Million | 682.21 Million | 801.13 Million | 2.9 Billion | 726.57 Million | 795.2 Million |
| Interest Expense | 9.32 Million | 5.12 Million | 4.61 Million | 31.25 Million | 8.39 Million | 9 Million |
| Income Tax Expense | 93.17 Million | 70.85 Million | 58.39 Million | 269.05 Million | 97.62 Million | 40.08 Million |
| Earnings before Tax | 606.08 Million | 548.08 Million | 531.72 Million | 2.26 Billion | 633.05 Million | 571 Million |
| Net Income | 512.81 Million | 477.64 Million | 473.18 Million | 1.99 Billion | 535.54 Million | 530.94 Million |
| Earnings Per Share Basic | 0.59 | 0.55 | 0.54 | - | 0.61 | 0.61 |
| Earnings Per Share Diluted | 0.59 | 0.55 | 0.54 | - | 0.61 | 0.61 |
| Weighted Average Shares Outstanding | 871.86 Million | 871.86 Million | 871.86 Million | 871.87 Million | 871.86 Million | 871.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 871.86 Million | 871.86 Million | 871.86 Million | 871.87 Million | 871.86 Million | 871.86 Million |
| Gross Margin | 0.48 | 0.47 | 0.46 | 0.45 | 0.46 | 0.46 |
| EBIT Margin | 0.17 | 0.20 | 0.21 | - | 0.21 | 0.22 |
| Profit Margin | 0.13 | 0.13 | 0.11 | 0.13 | 0.14 | 0.13 |
| EBITDA | 686.24 Million | 751.61 Million | 874.26 Million | - | 799.02 Million | 866.14 Million |
| Earnings Before Tax Margin | 0.20 | 0.18 | 0.19 | 0.19 | 0.19 | 0.20 |
B24
INFREA
SRB
GFPT-R
PAH3
2OY